Minerva Neurosciences (NERV) Assets Average (2014 - 2026)

Minerva Neurosciences has reported Assets Average for 13 years, with the latest figure at $96.0 million in Q1 2026.

• For the quarter ending Q1 2026, Assets Average rose 174.51% year-over-year to $96.0 million; the trailing twelve-month figure through Mar 2026 stood at $96.0 million (up 174.51% YoY), and the FY2025 full-year result was $67.6 million, up 43.67% from the prior year.
• Assets Average for Q1 2026 stood at $96.0 million, up from $63.0 million in the prior quarter.
• The five-year high for Assets Average was $96.0 million in Q1 2026, with the low at $29.3 million in Q3 2025.
• Historically, Assets Average has averaged $55.3 million across 5 years, with a median of $57.4 million in 2022.
• Annual changes were most pronounced in 2022 — Assets Average plunged 38.53% — and 2026, when it surged 174.51%.
• Minerva Neurosciences' Assets Average stood at $57.4 million in 2022, then rose by 4.51% to $60.0 million in 2023, then plunged by 33.39% to $40.0 million in 2024, then soared by 57.66% to $63.0 million in 2025, then soared by 52.3% to $96.0 million in 2026.
• The last three Assets Average figures came in at $96.0 million (Q1 2026), $63.0 million (Q4 2025), and $29.3 million (Q3 2025), per Business Quant data.